The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: A meta-analysis

Journal of Human Genetics

Volumn 50, Issue 6, 2005, Pages 267-275

  Zintzaras, Elias ^a   Chatzoulis, Dimitrios Z ^a   Karabatsas, Costas H ^a   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

C677T; Diabetic retinopathy; Meta analysis; MTHFR; Polymorphism; Type 2 diabetes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ASIAN; CAUCASIAN; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIABETIC RETINOPATHY; DNA POLYMORPHISM; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 23844441200     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-005-0250-z     Document Type: Article

References (57)

1. Best RM, Chakravarthy U (1997) Diabetic retinopathy in pregnancy. Br J Ophthalmol 81:249-251
2. Bostom AG, Selhub J, Jacques PF, Rosenberg IH (2001) Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135:133-137
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274:1049-1057
4. Buysschaert M, Gala JL, Bessomo A, Hermans MP (2004) C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia. Diabetes Metab 30:349-354
5. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
6. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477-485
7. Constans J, Blann AD, Resplandy F, Parrot F, Seigneur M, Renard M, Amiral J, Guerin V, Boisseau MR, Conri C (1999) Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. Atherosclerosis 147:411-413
8. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
10. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Kamoi K, Ito S (1999) No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. J Diabetes Complicat 13:284-287
11. Goldstein M, Leibovitch I, Yeffimov I, Gavendo S, Sela BA, Loewenstein A (2004) Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy. Eye 18:460-465
12. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200
13. Higgins JP, Thompson SE (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
14. Hoogeveen EK, Kostense PJ, Eysink PE, Polak BC, Beks PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD (2000) Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med 160:2984-2990
15. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47:821-830
16. Ioannidis JP, Ntzani EE, Trikalinos TA (2004) "Racial" differences in genetic effects for complex diseases. Nat Genet 36:1312-1318
17. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571
18. Kang SS, Wong PW, Bock HG, Horwitz A, Grix A (1991) Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48:546-551
19. Klein R, Klein BE, Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875-1891
20. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254
21. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826
22. Lewis PO, Zaykin D (2001) Genetic data analysis: computer program for the analysis of allelic data. Version 1.0 (d16c). Free program distributed by the authors over the internet from http://lewis.eeb.uconn.edu/lewishome/software. html
23. Maeda M, Yamamoto I, Fujio Y, Azuma J (2003a) Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta 1623:41-46
24. Maeda M, Yamamoto I, Fukuda M, Nishida M, Fujitsu J, Nonen S, Igarashi T, Motomura T, Inaba M, Fujio Y, Azuma J (2003b) Diabetic retinopathy possibly results from poor blood sugar control associated with MTHFR gene polymorphism in type 2 diabetic patients. Diabetes Care 26:1948
25. Maeda M, Yamamoto I, Fukuda M, Nishida M, Fujitsu J, Nonen S, Igarashi T, Motomura T, Inaba M, Fujio Y, Azuma J (2003c) MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation. Diabetes Care 26:547-548
26. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128
27. McCully KS (1996) Homocysteine and vascular disease. Nat Med 2:386-389
28. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W (2003) Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 18:1535-1540
29. Muncer S (2002) Response to: Power dressing and meta-analysis: incorporating power analysis into meta-analysis. J Adv Nursing 38:274-280
30. Munier A, Gunning T, Kenny D, O'Keefe M (1998) Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 82:630-633
31. Neugebauer S, Baba T, Kurokawa K, Watanabe T (1997) Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 349:473-474
32. Perna AF, Castaldo P, Ingrosso D, De Santo NG (1999) Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. J Nephrol 12:230-240
33. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P (2004) Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53:861-864
34. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF (2004) Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 279:14844-14852
35. Santos KG, Tschiedel B, Schneider J, Souto K, Roisenberg I (2003) Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 61:133-136
36. Shpichinetsky V, Raz I, Friedlander Y, Goldschmidt N, Wexler ID, Ben Yehuda A, Friedman G (2000) The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 130:2493-2497
37. Silverman EK, Palmer LJ (2000) Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22:645-648
38. Simonelli F, Testa F, Bandello F (2001) Genetics of diabetic retinopathy. Semin Ophthalmol 16:41-51
39. Sun J, Xu Y, Zhu Y, Lu H (2004) Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64:185-190
40. Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y (2003) The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus. Chin Med J (Engl) 116:145-147
41. The Diabetes Control, Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
42. The Diabetes Control, Complications Trial Research Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839
43. Thomas DC, White JS (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11:505-512
44. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
45. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245-251
46. Walker JM, Cove DH, Beevers DG, Dodson PM, Leatherdale BA, Fletcher RF, Wright AD (1985) Cigarette smoking, blood pressure and the control of blood glucose in the development of diabetic retinopathy. Diabetes Res 2:183-186
47. Warpeha KM, Chakravarthy U (2003) Molecular genetics of microvascular disease in diabetic retinopathy. Eye 17:305-311
48. Weir BS (1996) Genetic data analysis II: methods for discrete population genetic data. Sinauer Associates, Sunderland, MA, USA
49. Whitehead A (1997) A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med 16:2901-2913
50. Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester
51. Xu J, Turner A, Little J, Bleecker ER, Meyers DA (2002) Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?. Hum Genet 111:573-574
52. Yanko L, Goldbourt U, Michaelson IC, Shapiro A, Yaari S (1983) Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol 67:759-765
53. Yoshioka K, Yoshida T, Takakura Y, Kogure A, Umekawa T, Toda H, Yoshikawa T (2003) No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy. Diabetes Care 26:1947-1948
54. Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, Yoshikawa T (2004) Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients. Diabet Med 21:1051-1052
55. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49:474-481
56. Zintzaras E, Ioannidis JP (2005) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28:123-137
57. Zintzaras E, Stefanidis I (2005) Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50:84-91